Synryn Pharma Private Limited, a active private limited company, was established on 20 September 2018 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U73200TG2018PTC126873. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Ravi Keerthi (Director), Venkat Reddy Sappidi (Additional Director). Past directors included Vamshi Kiran Adelapuram, Narsaiah Chinthala, Ravinder Reddy Tippanna. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No 42-610, Mj Colony Moula Ali, Hyderabad, Telangana, 500040.
U73200TG2018PTC126873
126873
20 September 2018
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Synryn Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravi Keerthi | Director | 25 Feb 2019 | Current |
| Venkat Reddy Sappidi | Additional Director | 06 Feb 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Feb 2019 | Past |
| Pramod Abcsdd | Director | 05 Jun 2020 | Past |
| Pramod Abcsdd | Additional Director | 04 Sep 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Synryn Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 19.96% increase. The company also saw a substantial improvement in profitability, with a 140.82% increase in profit. The company's net worth Soared by an impressive increase of 49.48%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Synryn Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Synryn Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Synryn Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synryn Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Synryn Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Synryn Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
The activity Venkat Reddy Sappidi was appointed as a Additional Director was appointed as a Additional Director on 06 Feb 2020 & has been associated with this company since 5 years 9 months . was completed.
The activity Ravi Keerthi was appointed as a Director was appointed as a Director on 25 Feb 2019 & has been associated with this company since 6 years 9 months . was completed.
Synryn Pharma Private Limited was registered on 20 Sep 2018 with Roc Hyderabad & aged 7 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Synryn Pharma Private Limited is U73200TG2018PTC126873.
Synryn Pharma Private Limited is headquartered at H.No 42-610, Mj Colony Moula Ali, Hyderabad, Telangana, 500040.
Synryn Pharma Private Limited was incorporated on 20 September 2018.
The current directors of Synryn Pharma Private Limited are
The primary industry of Synryn Pharma Private Limited is Pharma.
Synryn Pharma Private Limited is unlisted.
The authorized capital of Synryn Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX